| 查看: 463 | 回复: 0 | |||
[交流]
美国休斯顿卫理公会医院肿瘤中心诚招肿瘤分子生物学博后
|
|
One postdoctoral position is available involved in molecular mechanism research of tumor microenvironment in Dr. Jing Yang’s lab at the Houston Methodist Cancer Center. The candidate will be responsible for the projects to identify new biomarkers or therapeutic targets within the bone marrow microenvironment of multiple myeloma for better prevention, diagnosis, or therapy improvement. The translational research program at Dr. Yang’s lab aims to investigate the interplay between cancer cells and bone marrow stromal cells such as adipocytes, immune cells, and bone cells. And the association between obesity and cancer. These studies explore innovative approaches or strategies to prevent therapeutic resistance and improve chemo and immunotherapeutic efficacy and early detection of hematological malignancies. Please refer to the selected publications from Dr. Yang’s lab for more information (Science Translational Medicine (2016, PMID: 27559096); Science Translational Medicine (2019, PMID: 31142679); Cell Metabolism (2021, PMID: 33406405); Nature Communication (2022, PMID: 35760800). We seek a highly motivated and independent candidate with a recent Ph.D. and/or M.D. degree in one of the following (or relevant) areas: oncology, cancer metabolism, or immunology. A candidate with a strong molecular biology background is preferred. The position is opening now until filled. The pay scale follows the NIH guidelines. Interested applications, including curriculum vitae, a brief cover letter, and the contact information of three references should be sent to Dr.Yang: jyang2@houstonmethodist.org. Jing Yang, PhD Associate professor Houston Methodist Cancer Center Weill Cornell Medical College 6550 Fannin St., SM8-023 Houston, TX 77030 |
» 猜你喜欢
基金申报
已经有5人回复
基金委咋了?2026年的指南还没有出来?
已经有7人回复
国自然申请面上模板最新2026版出了吗?
已经有17人回复
纳米粒子粒径的测量
已经有8人回复
疑惑?
已经有5人回复
计算机、0854电子信息(085401-058412)调剂
已经有5人回复
Materials Today Chemistry审稿周期
已经有5人回复
溴的反应液脱色
已经有7人回复
推荐一本书
已经有12人回复
常年博士招收(双一流,工科)
已经有4人回复











回复此楼